Valuation: IRADIMED CORPORATION

Market Cap 1.04B 924M 848M 770M 1.45B 98.03B 1.48B 10.13B 4.06B 51.88B 3.89B 3.81B 164B P/E 2026 *
42.4x
P/E 2027 * 36x
Enterprise Value 1.04B 924M 848M 770M 1.45B 98.03B 1.48B 10.13B 4.06B 51.88B 3.89B 3.81B 164B EV / Sales 2026 *
11.3x
EV / Sales 2027 * 10.1x
Free-Float
64.82%
Yield 2026 *
-
Yield 2027 * -
1 day+9.21%
1 week+5.54%
Current month+15.52%
1 month+2.44%
3 months-4.89%
6 months+4.31%
Current year-8.94%
1 week 76.35
Extreme 76.35
89.17
1 month 76.35
Extreme 76.35
91.05
Current year 76.35
Extreme 76.35
107.9
1 year 76.35
Extreme 76.35
107.9
3 years 39.24
Extreme 39.24
107.9
5 years 26
Extreme 26
107.9
10 years 7.85
Extreme 7.85
107.9
Manager TitleAgeSince
Chief Executive Officer 72 28/05/2020
Director of Finance/CFO 64 20/06/2022
Chief Tech/Sci/R&D Officer - 01/01/2020
Director TitleAgeSince
Chairman 72 16/06/2020
Director/Board Member 70 01/01/2019
Director/Board Member 73 01/01/2014
Date Insider Type Main position Quantity % Market Cap. Importance
23/9/26 Exercice

Director

1,396 0.0109%
3/9/26 Sell

Director

-1,419 0.0111%
4/6/26 Sell

Director

-3,000 0.0235%
Change 5-day change 1-year change 3-year change Capi.($)
+9.21%+5.54%+2.13%+108.72% 1.04B
+1.12%+0.29%+24.93%+55.19% 259B
+2.09%+0.37%+9.87%+20.16% 162B
+9.38%+8.54%-10.53%+73.88% 153B
+5.33%+7.99%-53.64%-13.24% 63.04B
+3.46%+7.12%-8.13%-6.52% 54.01B
+4.39%+8.27%+18.09%+48.09% 54.87B
+2.45%-2.26%+5.84%+58.36% 49.09B
+0.97%-2.37%+21.28%+64.76% 49.47B
+1.67%-1.95%+27.29%+85.45% 45.18B
Average +4.06%-0.91%+3.71%+49.49% 89.01B
Weighted average by Cap. +3.47%-0.55%+6.95%+45.30%

Financials

2026 *2027 *
Net sales 91.93M 81.92M 75.13M 68.27M 128M 8.69B 131M 898M 360M 4.6B 345M 338M 14.57B 102M 91.16M 83.6M 75.97M 143M 9.67B 146M 999M 401M 5.12B 384M 376M 16.21B
Net income 24.57M 21.89M 20.08M 18.24M 34.3M 2.32B 35.08M 240M 96.19M 1.23B 92.21M 90.24M 3.89B 28.8M 25.66M 23.54M 21.39M 40.21M 2.72B 41.13M 281M 113M 1.44B 108M 106M 4.56B
Net Debt - -
Projected Income Statement - Annual - IRADIMED CORPORATION
Logo IRADIMED CORPORATION
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories, disposables and services. Its MRidium 3870 MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium 3860+ MRI Compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to safely and predictably and other IV fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably on magnetic fields of over 30,000 gauss.
Employees
166
Date Price Change Volume
05/11/26 US$88.58 +9.21% 184,054
03/11/26 US$81.11 +2.13% 169,099
02/11/26 US$79.42 +3.57% 203,504
30/10/26 US$76.68 -10.57% 218,005
29/10/26 US$85.74 +2.16% 92,624
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
MarketScreener Ratings - IRADIMED CORPORATION
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
81.11USD
Average target price
118.00USD
Spread / Average Target
+45.48%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - IRADIMED CORPORATION
  1. Stock Market
  2. Stocks
  3. IRMD Stock